Dr Reddys Laboratories (RDY) Net Income towards Common Stockholders (QoQ) (2009 - 2023)
Dr Reddys Laboratories (RDY) Net Income towards Common Stockholders (QoQ) (2009 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.84 Bn | 9.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 5.33% |
| Mar 31, 2023 | 44.44% |
| Dec 31, 2022 | 76,973,584.21% |
| Jun 30, 2021 | 74.03% |
| Sep 30, 2020 | -172.48% |
| Jun 30, 2020 | 88.61% |
| Sep 30, 2019 | -152.29% |
| Jun 30, 2019 | 62.77% |
| Mar 31, 2019 | 49.21% |
| Dec 31, 2018 | -10.00% |
| Sep 30, 2018 | 1.45% |
| Jun 30, 2018 | 9.52% |
| Mar 31, 2018 | 43.18% |
| Dec 31, 2017 | -13.73% |
| Dec 31, 2016 | -43.53% |
| Mar 31, 2016 | 19.23% |
| Dec 31, 2015 | -11.36% |
| Sep 30, 2015 | -20.00% |
| Dec 31, 2014 | -15.31% |
| Mar 31, 2014 | -3.16% |